Results 161 to 170 of about 45,389 (224)

Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. [PDF]

, 1991
Abu-Elmaged, K, Alessiani, M, Demetris, A, Fung, JJ, Jain, A, Starzl, TE, Todo, S, Tzakis, A   +7 more
core  

Finerenone as an add-on treatment to conventional therapies for the patients with diabetic kidney disease. [PDF]

BMC Nephrol
Kidoguchi S, Naoki S, Suehiro Y, Yokoo T.   +3 more
europepmc   +1 more source

Management of adrenal insufficiency risk after long-term systemic glucocorticoid therapy in Duchenne muscular dystrophy: Clinical practice recommendations [PDF]

, 2019
Bowden, Sasigarn A, Connolly, Anne M, Kinnett, Kathi, Zeitler, Philip S   +3 more
core   +1 more source

Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome Associated With Baclofen and Diazepam. [PDF]

Cureus
Yamamoto Y, Matsushita A, Yamashita T, Tanaka K.   +3 more
europepmc   +1 more source

Association between acute respiratory acidosis and hyperkalemia during esophageal cancer surgery in the prone position: A multicenter retrospective observational study protocol. [PDF]

PLoS One
Okamoto S, Tochii T, Nakada J, Note H.
europepmc   +1 more source

Efficacy and Safety of Baxdrostat in Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Cureus
Wadhwani A, Khasbage SU, Zade SR, Singh MP, Keche Y, Ahire PM.   +5 more
europepmc   +1 more source

Effect of early everolimus-facilitated reduction of acrolimus on efficacy and renal function in de novo liver transplant recipients: 24-month results for the North American subpopulation [PDF]

, 2017
Chapman, William C, et al,
core   +1 more source

Meta-analysis of the efficacy and safety of Finerenone in diabetic kidney disease. [PDF]

Medicine (Baltimore)
Chen K, Shao W, Zhang H.
europepmc   +1 more source

Nafamostat mesylate in renal replacement therapy: balancing efficacy with emerging risks of hyperkalemia. [PDF]

Ren Fail
Mali N, Tang Y, Mali S, Sun X, Zhang L, Fu P.   +5 more
europepmc   +1 more source